Early response in phosphorylation of ribosomal protein S6 is associated with sensitivity to trametinib in colorectal cancer cells

Mutations in RAS or BRAF are associated with poor prognosis and resistance to epidermal growth factor receptor (EGFR)-targeted therapy in colorectal cancer (CRC). Despite their common ability to activate downstream genes such as MEK and ERK, the therapeutic benefit of MEK inhibitors for patients wit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Laboratory investigation 2021-08, Vol.101 (8), p.1036-1047
Hauptverfasser: Hirashita, Yuka, Tsukamoto, Yoshiyuki, Kudo, Yoko, Kakisako, Daisuke, Kurogi, Shusaku, Hijiya, Naoki, Nakada, Chisato, Uchida, Tomohisa, Hirashita, Teijiro, Hiratsuka, Takahiro, Akagi, Tomonori, Ueda, Yoshitake, Shiroshita, Hidefumi, Etoh, Tsuyoshi, Mizukami, Kazuhiro, Honda, Koichi, Okimoto, Tadayoshi, Kodama, Masaaki, Inomata, Masafumi, Moriyama, Masatsugu, Murakami, Kazunari
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!